Our previous study revealed that FLT3 or DNA methyltransferase 3A (DNMT3A) mutant AML cells overexpressed CD44v6 and CD44v6 CAR-T cells are significantly effective against them (9). This evidence concerns the gene FLT3 and acute myeloid leukemia.